Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
28.46
+0.05 (0.18%)
At close: Dec 5, 2025, 4:00 PM EST
28.50
+0.04 (0.14%)
After-hours: Dec 5, 2025, 7:58 PM EST
Teva Pharmaceutical Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Teva Pharmaceutical stock ranges from a low of $22 to a high of $35. The average analyst price target of $27 forecasts a -5.13% decrease in the stock price over the next year.
Price Target: $27.00 (-5.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Teva Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Initiates $35 | Buy | Initiates | $35 | +22.98% | Dec 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $26 → $28 | Buy | Maintains | $26 → $28 | -1.62% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $26 | Buy | Maintains | $23 → $26 | -8.64% | Oct 3, 2025 |
| UBS | UBS | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | -8.64% | Sep 24, 2025 |
| UBS | UBS | Strong Buy Maintains $24 → $23 | Strong Buy | Maintains | $24 → $23 | -19.18% | Jun 26, 2025 |
Financial Forecast
Revenue This Year
17.33B
from 16.54B
Increased by 4.74%
Revenue Next Year
17.41B
from 17.33B
Increased by 0.48%
EPS This Year
2.70
from -1.45
EPS Next Year
2.80
from 2.70
Increased by 3.95%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 18.0B | 18.2B | |
| Avg | 17.3B | 17.4B | |
| Low | 16.5B | 16.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.0% | 4.8% | |
| Avg | 4.7% | 0.5% | |
| Low | -0.0% | -4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.88 | 2.99 | |
| Avg | 2.70 | 2.80 | |
| Low | 2.54 | 2.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 11.0% | |
| Avg | - | 4.0% | |
| Low | - | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.